The long-term safety and effectiveness of natalizumab (IMSE 1) - Real-world data from a Swedish nationwide pharmaco-epidemiological study E. Ekstrom, V. Rosengren, S. Kagstrom,L. Forsberg,A. Berglund,J. Hillert, P. Nilsson,C. Dahle,A. Svenningsson, J. Lycke,A. -M. Landtblom,J. Burman,C. Martin, P. Sundstrom,M. Gunnarsson,F. Piehl,T. OlssonMULTIPLE SCLEROSIS JOURNAL（2021）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
